In recent years, decentralized clinical trials have generated much discussion for the pharmaceutical industry. Decentralized trials offer a new model of clinical research that incorporates new technologies and remote assessments, with the aim to gather more diverse and inclusive data and offer improved patient care. With the move to a patient-centric approach, decentralized trials are finding ways to accommodate various patient needs that are often neglected in traditional trials. In the ongoing COVID-19 pandemic, the pharmaceutical industry has been forced to meet operational challenges with innovative solutions that make use of technological advances. With the disruption of in-person activities, research.. READ MORE »
